Skip to content
    Eight Roads Ventures logo

    Eight Roads Ventures

    London, United KingdomFounded 1969

    Eight Roads Ventures is a global venture capital firm that primarily invests in technology and healthcare companies, backing them from early to growth stages. Their strategy involves providing patient capital and strategic guidance to help portfolio companies achieve global scale.

    Deal activity decreased year-over-year (4 deals in the last 12 months vs 6 prior). Average disclosed round size is $69.0M (across 84 rounds with reported amounts).

    Find people at Eight Roads Ventures on Goldilocks AI

    Portfolio

    89

    Fund Size

    $8B

    Top Stage

    Series B

    Last 12 Mo

    4

    Team

    Lucile Cornet

    Lucile Cornet

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    89 investments
    CompanyRoundAmountDate
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries B$85MJan 2026
    Amenitiz logoAmenitizSeries B$45MNov 2025
    AABK Biomedical, Inc.Series D$35MOct 2025
    SAFE logoSAFESeries C$70MJul 2025
    AArnatar TherapeuticsSeries A$52MDec 2024
    Lighthouse logoLighthouseSeries C$370MNov 2024
    EEverstageSeries B$30MOct 2024
    Eon logoEonSeries B$127MOct 2024
    HHERO SoftwareSeries B$40MJul 2024
    Odaseva logoOdasevaSeries C$54MJun 2024
    Pelago logoPelagoSeries C$58MMar 2024
    HHiLabsSeries B$39MMar 2024
    Shadowfax logoShadowfaxSeries E$100MFeb 2024
    PlasmaGen Biosciences logoPlasmaGen BiosciencesUnknown$27MDec 2023
    Adcentrx Therapeutics logoAdcentrx TherapeuticsSeries A$51MDec 2023
    ScyllaDB logoScyllaDBSeries C$43MOct 2023
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries A$70MJul 2023
    Adcentrx Therapeutics logoAdcentrx TherapeuticsSeries A$38MApr 2023
    Safe Security logoSafe SecuritySeries B$50MApr 2023
    AAden FinancialSeries AMar 2023
    CCoho AISeed$8.5MJan 2023
    AABK Biomedical, Inc.Series C$30MDec 2022
    Red Points logoRed PointsGrowth$20MNov 2022
    Elucidata logoElucidataSeries A$16MSep 2022
    Enko logoEnkoSeries C$70MJul 2022
    Page 1 of 4

    Top Co-Investors

    Last updated: 12 April 2026